DK133942B - Analogifremgangsmåde til fremstilling af 1,3-disubstituerede pyrrolidiner eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 1,3-disubstituerede pyrrolidiner eller syreadditionssalte deraf.

Info

Publication number
DK133942B
DK133942B DK551967A DK551967A DK133942B DK 133942 B DK133942 B DK 133942B DK 551967 A DK551967 A DK 551967A DK 551967 A DK551967 A DK 551967A DK 133942 B DK133942 B DK 133942B
Authority
DK
Denmark
Prior art keywords
preparation
acid addition
addition salts
analogous process
disubstituted pyrrolidines
Prior art date
Application number
DK551967A
Other languages
English (en)
Other versions
DK133942C (da
Inventor
Carl Dalton Lunsford
William John Welstead Jr
Grover Cleveland Helsley
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Priority to DK490274A priority Critical patent/DK135163B/da
Publication of DK133942B publication Critical patent/DK133942B/da
Application granted granted Critical
Publication of DK133942C publication Critical patent/DK133942C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK551967A 1966-11-07 1967-11-06 Analogifremgangsmåde til fremstilling af 1,3-disubstituerede pyrrolidiner eller syreadditionssalte deraf. DK133942B (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK490274A DK135163B (da) 1966-11-07 1974-09-17 3-Substituerede pyrrolidiner eller syreadditionssalte deraf til anvendelse som mellemprodukter ved fremstillingen af terapeutisk aktive 1,3-disubstituerede pyrrolidiner eller syreadditionssalte deraf.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59226366A 1966-11-07 1966-11-07

Publications (2)

Publication Number Publication Date
DK133942B true DK133942B (da) 1976-08-16
DK133942C DK133942C (da) 1977-01-24

Family

ID=24369972

Family Applications (1)

Application Number Title Priority Date Filing Date
DK551967A DK133942B (da) 1966-11-07 1967-11-06 Analogifremgangsmåde til fremstilling af 1,3-disubstituerede pyrrolidiner eller syreadditionssalte deraf.

Country Status (12)

Country Link
AT (1) AT272331B (da)
BE (1) BE704683A (da)
CA (1) CA955936A (da)
CH (1) CH511834A (da)
DE (1) DE1695652A1 (da)
DK (1) DK133942B (da)
ES (1) ES346816A1 (da)
FR (2) FR1575543A (da)
GB (1) GB1202747A (da)
IL (1) IL28811A (da)
NL (1) NL6714553A (da)
SE (1) SE315594B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54151990A (en) * 1978-04-17 1979-11-29 Beiersdorf Ag Novel condensated nitrogenncontained heterocyclic compound and its manufacture
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
CN101808987A (zh) 2007-06-05 2010-08-18 Nsab神经研究瑞典公司分公司 作为皮层儿茶酚胺能神经传递调节剂的二取代的苯基吡咯烷

Also Published As

Publication number Publication date
AT272331B (de) 1969-07-10
CH511834A (de) 1971-08-31
DE1695652A1 (de) 1971-04-29
FR1575543A (da) 1969-07-25
FR7535M (da) 1969-12-22
BE704683A (da) 1968-02-15
NL6714553A (da) 1968-05-08
IL28811A (en) 1971-07-28
ES346816A1 (es) 1969-04-16
SE315594B (da) 1969-10-06
GB1202747A (en) 1970-08-19
DK133942C (da) 1977-01-24
CA955936A (en) 1974-10-08

Similar Documents

Publication Publication Date Title
DK130070B (da) Analogifremgangsmåde til fremstilling af 3,4-dihydroxyphenylalkanolaminer eller syreadditionssalte deraf.
DK125417B (da) Analogifremgangsmåde til fremstilling af amino-dihalogenphenylethylaminer eller syreadditionssalte deraf.
DK115847B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 2,4-diamino-5-benzyl-pyrimidinderivater eller syreadditionssalte deraf.
DK115473B (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetrahydro-1H-3-benzazepiner eller syreadditionssalte deraf.
DK108496C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner eller syreadditionssalte deraf.
DK124404B (da) Fremgangsmåde til fremstilling af 2-arylamino-1,3-diazacycloalkener-(2) eller syreadditionssalte deraf.
DK121905C (da) Fremgangsmåde til fremstilling af N-alkylminoalkylderivater af spirotetralinsuccinimider eller syreaddionssalte deraf.
DK120389B (da) Fremgangsmåde til fremstilling af 2-cycloalkylaminooxazoliner eller syreadditionssalte deraf.
DK120400B (da) Analogifremgangsmåde til fremstilling af 1-(3,5-dihalogen-4-hydroxyphenyl)-2-(2-phenoxy- eller 2-phenylalkyl-isopropylamino)-propanoler eller syreadditionssalte deraf.
DK132411B (da) Analogifremgangsmåde til fremstilling af pyrrylaminoketonderivater eller syreadditionssalte deraf.
DK131721B (da) Analogifremgangsmåde til fremstilling af adamantanylaminer eller 3,5,7-trimethylhomologe eller syreadditionssalte deraf.
DK120548B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller 4-oxider eller syreadditionssalte deraf.
DK121367B (da) Analogifremgangsmåde til fremstilling af 3,3-difenylallylaminderivater eller syreadditionssalte deraf.
DK135231B (da) Analogifremgangsmåde til fremstilling af basisk substituerede 2,3-cis, trans-diphenylcyclopropanderivater eller syreadditionssalte deraf.
DK115851B (da) Fremgangsmåde til fremstilling af 1,2-dihydro-4-aryl-quinazoliner eller syreadditionssalte deraf.
DK115849B (da) Fremgangsmåde til fremstilling af substituerede 2-anilinomethyl-imidazoliner eller syreaddtitionssalte heraf.
DK115110B (da) Fremgangsmåde til fremstilling af anticholeterolemeisk sktive 25-aza-19-nor-1,3,5(10)-cholestatriener eller syreadditionssalte deraf.
DK118663B (da) Analogifremgangsmåde til fremstilling af basisk substituerede derivater af 5,6-dihydro-dibenz-[b,e]-azepin-6, 11-dion-11-oxim eller syreadditionssalte deraf.
DK133942B (da) Analogifremgangsmåde til fremstilling af 1,3-disubstituerede pyrrolidiner eller syreadditionssalte deraf.
DK116662B (da) Fremgangsmåde til fremstilling af pyrazinamider eller syreadditionssalte deraf.
DK125175B (da) Analogifremgangsmåde til fremstilling af lysergsyre- eller 9,10-dihydrolysergsyrederivater eller syreadditionssalte heraf.
DK118657B (da) Analogifremgangsmåde til fremstilling af 3',4',5'-trimethoxy-3-aminoacrylophenoner eller syreadditionssalte deraf.
DK121125B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK119826B (da) Fremgangsmåde til fremstilling af α-6-deoxytetracyclin, α-6-deoxy-5-oxytetracyclin eller syreadditionssalte deraf.
DK125552B (da) Fremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolin-2-carboxamidiner eller syreadditionssalte deraf.